High renin and prorenin in plasma and pleural exudate of a patient with the ovarian hyperstimulation syndrome

Netherlands Journal of Medicine

Volumn 51, Issue 6, 1997, Pages 232-236

  Van de Vrie, W ^a   Baggen, M G A ^a   Visser, W ^b   Derkx, F H M ^b   Morrel, B ^a   Ouwendijk, R J Th ^a  

^a IKAZIA HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Ovarian hyperstimulation syndrome; Pleural effusion; Renin angiotensin system; Thoracentesis

Indexed keywords

PRORENIN; RENIN;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; INFERTILITY; NETHERLANDS; OVARY DISEASE; OVULATION INDUCTION; PLEURA EFFUSION; PLEURA FLUID; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; THORACOCENTESIS;

ABORTION, SPONTANEOUS; ADULT; CHORIONIC GONADOTROPIN; ENZYME PRECURSORS; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; INFERTILITY, FEMALE; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PLEURAL EFFUSION; PREGNANCY; RENIN; THORACOSTOMY;

EID: 0031444591     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(97)00065-X     Document Type: Article

References (26)

1. Golan A, Ron-El R, Herman A, Soffer Y, Weinraub Z, Caspi E. Ovarian hyperstimulation syndrome: an Update review. Obstet Gynecol Surv 1989;44:430-440.
2. Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 1992;58:249-261.
3. Brinsden PR, Wada I, Tan SL, Balen A, Jacobs HS. Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol 1995;102:767-772.
4. Smitz J, Camus M, Devroey P, Erard P, Wisanto A, Van Steirteghem AC. Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/HMG superovulation for in-vitro fertilization. Hum Reprod 1990;5:933-937.
5. Rizk B, Smitz J. Ovarian hyperstimulation syndrome after superovulation using GnRH agonists for IVF and related procedures. Hum Reprod 1992;7:320-327.
6. Delvigne A, Demoulin A, Smitz J, et al. The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study I. Clinical and biological features. Hum Reprod 1993;8:1353-1360.
7. Schenker JG. Prevention and treatment of ovarian hyperstimulation. Hum Reprod 1993;8:653-659.
8. Bergh PA, Navot D. Ovarian hyperstimulation syndrome: a review of pathophysiology. J Assist Reprod Genet 1992;9:429-438.
9. Navot D, Margalioth EJ, Laufer N, et al. Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome. Fertil Steril 1987;48:57-61.
10. Ong ACM, Elsen V, Rennie DP, et al. The pathogenesis of the ovarian hyperstimulation syndrome (OHS): a possible role for ovarian renin. Clin Endocrinol 1991;34:43-49.
11. Delbaere A, Bergmann PJM, Gervy-Decoster C, Staroukine M, Englert Y. Angiotensin II immunoreactivity is elevated in ascites during severe ovarian hyperstimulation syndrome: implications for pathophysiology and clinical management. Fertil Steril 1994;62:731-737.
12. Rosenberg ME, Mckenzie JK, Mckenzie IM, Junaid A, Tagatz GE. Increased ascitic fluid prorenin in the ovarian hyperstimulation syndrome. Am J Kidney Dis 1994;23:427-429.
13. Itskovitz-Eldor J, Kol S, Lewit N, Sealey JE. Ovarian origin of plasma and peritoneal fluid prorenin in early pregnancy and in patients with ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 1997;82:461-464.
14. Friedlander MA, Loret de Mola JR, Goldfarb JM. Elevated levels of interleukin-6 in ascites and serum from women with ovarian hyperstimulation syndrome. Fertil Steril 1993;60:826-833.
15. Orvieto R, Voliovitch I, Fishman P, Ben-Rafael Z. Interleukin-2 and ovarian hyperstimulation syndrome: a pilot study. Hum Reprod 1995;10:24-27.
16. Revel A, Barak V, Lavy Y, et al. Characterization of intraperitoneal cytokines and nitrites in women with severe ovarian hyperstimulation syndrome. Fertil Steril 1996;66:66-71.
17. McClure N, Healy DL, Rogers PAW, et al. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 1994;344:235-236.
18. Abramov Y, Barak V, Nisman B, Schenker JG. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil Steril 1997;67:261-265.
19. Morris RS, Paulson RJ. Ovarian derived prorenin - angiotensin cascade in human reproduction. Fertil Steril 1994;62:1105-1114.
20. Balasch J, Arroyo V, Carmona F, et al. Severe ovarian hyperstimulation syndrome: role of peripheral vasodilation. Fertil Steril 1991;56:1077-1083.
21. Balasch J, Arroyo V, Fábregues F, et al. Neurohormonal and hemodynamic changes in severe cases of the ovarian hyperstimulation syndrome. Ann Intern Med 1994;121:27-33.
22. Balasch J, Arroyo V, Fábregues F, Jiménez W, Saló J, Vanrell JA. Immunoreactive endothelin plasma levels in severe ovarian hyperstimulation syndrome. Fertil Steril 1995;64:65-68.
23. Borenstein R, Elhalah U, Lunenfeld B, Shoham Schwartz Z. Severe ovarian hyperstimulation syndrome: a reevaluated therapeutic approach. Fertil Steril 1989;51:791-795.
24. Padilla SL, Zamaria S, Baramki TA, Garcia JE. Abdominal paracentesis for the ovarian hyperstimulation syndrome with severe pulmonary compromise. Fertil Steril 1990;53:365-367.
25. Hsieh MJ, Tsao TC, Cheng PJ. Ovarian hyperstimulation syndrome with minimal ascites and massive pleural effusion: report of a case. J Formos Med Assoc 1994;93:882-884.
26. Rinaldi ML, Spirtos NJ. Chest tube drainage of pleural effusion correcting abdominal ascites in a patient with severe ovarian hyperstimulation syndrome: a case report. Fertil Steril 1995;63:1114-1117.